tiprankstipranks
Fulcrum Therapeutics (FULC)
NASDAQ:FULC
US Market

Fulcrum Therapeutics (FULC) Cash flow

Compare
486 Followers

Fulcrum Therapeutics Cash Flow

FULC's free cash flow for Q2 2024 was $-19.09M. For the 2024 fiscal year, FULC's free cash flow was decreased by $7.54M and operating cash flow was $-19.07M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -90.97M$ -97.05M$ -78.48M$ -53.66M$ -39.48M
Investing Cash Flow
$ -36.69M$ 12.41M$ -129.67M$ -57.14M$ -944.00K
Financing Cash Flow
$ 118.12M$ 84.32M$ 186.51M$ 71.13M$ 64.34M
End Cash Position
$ 26.66M$ 36.19M$ 36.50M$ 58.14M$ 97.81M
Free Cash Flow
$ -91.47M$ -99.01M$ -80.19M$ -55.00M$ -40.34M
Currency in USD

Fulcrum Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis